SEC Form 4 · accession 0001140361-15-007952
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan W Ayers
Officer — Chairman, President & CEO · Director
Period of report
Feb 17, 2015
Accepted (ET)
Feb 19, 2015 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 17, 2015 | M | 12,500 | $34.37 | A | 446,623 | D | |
| Common Stock | Feb 17, 2015 | M | 1,875 | $53.31 | A | 448,498 | D | |
| Common Stock | Feb 18, 2015 | M | 2,502 | $34.37 | A | 451,000 | D | |
| Common Stock | holding | — | — | — | 49,000 | I | By Ayers Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $34.37 | Feb 17, 2015 | M | 12,500 | D | — | Feb 13, 2016 | Common Stock | 12,500 | 39,589 | D |
| Incentive Stock Option (right to buy)F2 | $53.31 | Feb 17, 2015 | M | 1,875 | D | — | Feb 13, 2017 | Common Stock | 1,875 | 0 | D |
| Non-Qualified Stock Option (right to buy)F1 | $34.37 | Feb 18, 2015 | M | 2,502 | D | — | Feb 13, 2016 | Common Stock | 2,502 | 37,087 | D |
Explanation of responses
- F1Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 15,999 shares on 02/14/2010 and 02/14/2013, 16,000 shares on 02/14/2011 and 02/14/2012, and the remaining 13,091 shares on 02/14/2014.
- F2Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested on the fifth anniversary date (02/14/2015) of the grant.